(3.238.99.243) 您好!臺灣時間:2021/05/15 19:10
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:徐千剛
研究生(外文):Chien-Gang
論文名稱:Nm23-H1及hTERT在子宮頸癌之表現
論文名稱(外文):Human Nonmetastatic Clone 23 Type 1 and Human Telomerase Reverse Transcriptase in Cancer of Uterine Cervix
指導教授:柯俊良柯俊良引用關係林隆堯林隆堯引用關係
學位類別:博士
校院名稱:中山醫學大學
系所名稱:醫學研究所
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:2009
畢業學年度:97
語文別:中文
論文頁數:103
相關次數:
  • 被引用被引用:0
  • 點閱點閱:104
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
Human nonmetastatic clone 23 (nm23-H1)和human telomerase reverse transcriptase (hTERT) 於高度子宮頸細胞內贅瘤 (high-grade cervical intraepithelial neoplasia) 及侵入性子宮頸癌 (invasive cervical cancer) 組織切片之免疫組織化學表現有增強趨勢,但是hTERT 免疫組織化學表現和子宮頸癌臨床病理特徵似乎較沒有關係,而nm23-H1 和子宮頸癌臨床病理特徵及預後存活似乎較有關係。我們因而以子宮頸組織晶片,研究nm23-H1免疫組織化學染色之表現,檢驗nm23-H1 蛋白表現和病人子宮頸癌臨床病理特徵、復發及預後存活之關係。我們並以real time polymerase chain reaction 驗證,於子宮頸癌組織,nm23-H1 之mRNA 表現較其周邊正常組織對照組強。我們進一步發現,nm23-H1 免疫蛋白之表現和子宮頸癌基質侵犯深度 (P = 0.003) 、腫瘤大小 (P = 0.044) 及細胞分化 (P = 0.025) 有關,且nm23-H1 免疫化學染色強的子宮頸癌病人預後較差。

Human nonmetastatic clone 23 (nm23-H1) and human telomerase reverse
transcriptase (hTERT) may be separately involved in tumor progression of
uterine cervix. Moreover, we found normal cervix and cervical low-grade
intraepithelial neoplsia (low-grade CIN) samples had concurrent low expression
of hTERT and nm23-H1, whereas high-grade CIN [CIN2 (moderate dysplasia)
and CIN3 (severe dysplasia, carcinoma in situ)] SCC samples had concurrent
high immunoreactivity. However, hTERT immunoreactivity seemed to have no
significant association with clinicopathological variables of cervical cancer. On
the contrary, only deep stromal invasion was significantly associated with high
nm23-H1 immunoreactivity based on our limited cervical tissue samples. A high
cumulative recurrence hazard was demonstrated for the high nm23-H1
expression group. Therefore, using real time polymerase chain reaction and
tissue microarray of cervical samples, we further demonstrated that nm23-H1
mRNA expression and H score (median H scores: 2.0 vs. 0.3, P = 0.001) were
higher in cervical cancer tissues than normal counterparts, respectively.
Nm23-H1 expression was significantly associated with depth of stromal
invasion (P = 0.003), tumor diameter (P = 0.044) and cell differentiation (P =
0.025). Furthermore, positive nm23-H1 expression was significantly associated
with poor overall survival.

致謝……………………………………………………………..………………2
中文摘要…………………………………………………………..……………4
英文摘要……………………………………………………………..…………5
前言……………………………………………………………..………………6
材料方法………………………………….........................................................18
結果 ………………………………...................................................................33
討論.....................................................................................................................39
結論.....................................................................................................................50
表格.....................................................................................................................51
圖………………………………………….........................................................60
參考文獻………………………………….........................................................77
已出版論文…………………………….............................................................87

1. Richart RM: Cervical intraepithelial neoplasia. Pathol Annu 1973,
8:301-328.
2. Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R,
Hong WK, Schottenfeld D: Cervical human papillomavirus infection
and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr
1996(21):17-25.
3. Traen K, Svane D, Kryger-Baggesen N, Bertelsen K, Mogensen O: Stage
Ib cervical cancer during pregnancy: planned delay in
treatment--case report. Eur J Gynaecol Oncol 2006, 27(6):615-617.
4. Proietto A: Gynaecological cancer surgery. Best Pract Res Clin Obstet
Gynaecol 2006, 20(1):157-172.
5. Gonzalez D, Hernandez E, Anderson L, Heller P, Atkinson BF: Clinical
Significance of a cervical cytologic diagnosis of atypical squamous
cells of undetermined significance. Favoring a reactive process or low
grade squamous intraepithelial lesion. J Reprod Med 1996,
41(10):719-723.
6. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of
cancer cells in metastatic sites. Nat Rev Cancer 2002, 2(8):563-572.
7. Overall CM, Lopez-Otin C: Strategies for MMP inhibition in cancer:
innovations for the post-trial era. Nat Rev Cancer 2002, 2(9):657-672.
8. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and
metabolism. Mol Cell Biol 1999, 19(1):1-11.
9. Straughn JM, Jr., Richter HE, Conner MG, Meleth S, Barnes MN:
Predictors of outcome in small cell carcinoma of the cervix--a case
series. Gynecol Oncol 2001, 83(2):216-220.
10. Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S,
Schnorr D, Loening SA, Lichtinghagen R: Differential expression of
matrix metalloproteinases and their tissue inhibitors in human
primary cultured prostatic cells and malignant prostate cell lines.
Prostate 2002, 50(1):38-45.
11. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME: Altered
expression of NM23, a gene associated with low tumor metastatic
potential, during adenovirus 2 Ela inhibition of experimental
metastasis. Cancer Res 1988, 48(22):6550-6554.
12. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS,
Fodstad O: Levels of nm23 messenger RNA in metastatic malignant
melanomas: inverse correlation to disease progression. Cancer Res
1992, 52(21):6088-6091.
13. Howlett AR, Petersen OW, Steeg PS, Bissell MJ: A novel function for
the nm23-H1 gene: overexpression in human breast carcinoma cells
leads to the formation of basement membrane and growth arrest. J
Natl Cancer Inst 1994, 86(24):1838-1844.
14. Kantor JD, McCormick B, Steeg PS, Zetter BR: Inhibition of cell
motility after nm23 transfection of human and murine tumor cells.
Cancer Res 1993, 53(9):1971-1973.
15. Leone A, Flatow U, VanHoutte K, Steeg PS: Transfection of human
nm23-H1 into the human MDA-MB-435 breast carcinoma cell line:
effects on tumor metastatic potential, colonization and enzymatic
activity. Oncogene 1993, 8(9):2325-2333.
16. Ohba K, Miyata Y, Koga S, Kanda S, Kanetake H: Expression of
nm23-H1 gene product in sarcomatous cancer cells of renal cell
carcinoma: correlation with tumor stage and expression of matrix
metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and
c-erbB-2. Urology 2005, 65(5):1029-1034.
17. Chen SY, Wang XQ, Li XM, Chen YX, Wu CQ: [Expressions of P16 and
nm23-H1 in nasopharyngeal cacinoma and their clinical significance].
Di Yi Jun Yi Da Xue Xue Bao 2005, 25(3):342-344, 348.
18. Che GW, Zhou QH, Zhu W, Wang YP, Qin Y, Liu LX, Chen XH, Sun YL,
Sun ZF: [Molecular mechanism of reversing metastatic phenotype in
human high-metastatic large cell lung cancer cell line L9981 by
nm23-H1]. Ai Zheng 2005, 24(3):278-284.
19. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC: Prognostic value of
nm23 expression in stage IB1 cervical carcinoma. Jpn J Clin Oncol
2001, 31(7):327-332.
20. Kogan EA, Shvets SI, Kovalenko VL, Soboleva Iu V: [Correlation of
proliferation, apoptosis, angiogenesis and metastasizing in various
histogenetic types of pulmonary cancer (an immunohistochemical
investigation)]. Arkh Patol 2004, 66(6):33-38.
21. Zheng CL, Wen JF, Huang Y: [Expression and significance of PTEN
and nm23 in the metastasis of gallbladder cancer]. Zhong Nan Da Xue
Xue Bao Yi Xue Ban 2005, 30(1):46-48.
22. Liu WK, Chu YL, Zhang F, Chen P, Cheng F, Wang H, Jia YY, Ma TY:
The relationship between HPV16 and expression of CD44v6, nm23H1
in esophageal squamous cell carcinoma. Arch Virol 2005,
150(5):991-1001.
23. Nosho K, Yamamoto H, Adachi Y, Endo T, Hinoda Y, Imai K: Gene
expression profiling of colorectal adenomas and early invasive
carcinomas by cDNA array analysis. Br J Cancer 2005,
92(7):1193-1200.
24. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM:
Extracellular signal-regulated kinase (ERK)-dependent gene
expression contributes to L1 cell adhesion molecule-dependent
motility and invasion. J Biol Chem 2004, 279(28):28880-28888.
25. Lo CH, Lee SC, Wu PY, Pan WY, Su J, Cheng CW, Roffler SR, Chiang
BL, Lee CN, Wu CW et al: Antitumor and antimetastatic activity of
IL-23. J Immunol 2003, 171(2):600-607.
26. Zollo M, Andre A, Cossu A, Sini MC, D''Angelo A, Marino N, Budroni M,
Tanda F, Arrigoni G, Palmieri G: Overexpression of h-prune in breast
cancer is correlated with advanced disease status. Clin Cancer Res
2005, 11(1):199-205.
27. Chen XF, Zhang HT, Qi QY, Sun MM, Tao LY: Expression of
E-cadherin and nm23 is associated with the clinicopathological
factors of human non-small cell lung cancer in China. Lung Cancer
2005, 48(1):69-76.
28. Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang
PC, Wu CW, Roffler SR: Tumor-associated antigen L6 and the
invasion of human lung cancer cells. Clin Cancer Res 2003,
9(7):2807-2816.
29. Hemmerich S, Yarden Y, Pecht I: A cromoglycate binding protein from
rat mast cells of a leukemia line is a nucleoside diphosphate kinase.
Biochemistry 1992, 31(19):4574-4579.
30. Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies
IM, King CR, Liotta LA, Steeg PS: Reduced Nm23/Awd protein in
tumour metastasis and aberrant Drosophila development. Nature
1989, 342(6246):177-180.
31. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg PS:
Identification of a second human nm23 gene, nm23-H2. Cancer Res
1991, 51(1):445-449.
32. Venturelli D, Martinez R, Melotti P, Casella I, Peschle C, Cucco C,
Spampinato G, Darzynkiewicz Z, Calabretta B: Overexpression of
DR-nm23, a protein encoded by a member of the nm23 gene family,
inhibits granulocyte differentiation and induces apoptosis in 32Dc13
myeloid cells. Proc Natl Acad Sci U S A 1995, 92(16):7435-7439.
33. Lombardi D, Lacombe ML, Paggi MG: nm23: unraveling its biological
function in cell differentiation. J Cell Physiol 2000, 182(2):144-149.
34. Mehus JG, Deloukas P, Lambeth DO: NME6: a new member of the
nm23/nucleoside diphosphate kinase gene family located on human
chromosome 3p21.3. Hum Genet 1999, 104(6):454-459.
35. Milon L, Rousseau-Merck MF, Munier A, Erent M, Lascu I, Capeau J,
Lacombe ML: nm23-H4, a new member of the family of human
nm23/nucleoside diphosphate kinase genes localised on chromosome
16p13. Hum Genet 1997, 99(4):550-557.
36. Munier A, Feral C, Milon L, Pinon VP, Gyapay G, Capeau J, Guellaen G,
Lacombe ML: A new human nm23 homologue (nm23-H5) specifically
expressed in testis germinal cells. FEBS Lett 1998, 434(3):289-294.
37. Tsuiki H, Nitta M, Furuya A, Hanai N, Fujiwara T, Inagaki M, Kochi M,
Ushio Y, Saya H, Nakamura H: A novel human nucleoside diphosphate
(NDP) kinase, Nm23-H6, localizes in mitochondria and affects
cytokinesis. J Cell Biochem 1999, 76(2):254-269.
38. Martinez R, Venturelli D, Perrotti D, Veronese ML, Kastury K, Druck T,
Huebner K, Calabretta B: Gene structure, promoter activity, and
chromosomal location of the DR-nm23 gene, a related member of the
nm23 gene family. Cancer Res 1997, 57(6):1180-1187.
39. Amendola R, Martinez R, Negroni A, Venturelli D, Tanno B, Calabretta B,
Raschella G: DR-nm23 gene expression in neuroblastoma cells:
relationship to integrin expression, adhesion characteristics, and
differentiation. J Natl Cancer Inst 1997, 89(17):1300-1310.
40. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO: The human
Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000,
32(3):247-258.
41. Sadek CM, Jimenez A, Damdimopoulos AE, Kieselbach T, Nord M,
Gustafsson JA, Spyrou G, Davis EC, Oko R, van der Hoorn FA et al:
Characterization of human thioredoxin-like 2. A novel
microtubule-binding thioredoxin expressed predominantly in the cilia
of lung airway epithelium and spermatid manchette and axoneme. JBiol Chem 2003, 278(15):13133-13142.
42. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23
RNA levels in human primary infiltrating ductal breast carcinomas
with lymph node involvement and other histopathological indicators
of high metastatic potential. Cancer Res 1989, 49(18):5185-5190.
43. Nakayama H, Yasui W, Yokozaki H, Tahara E: Reduced expression of
nm23 is associated with metastasis of human gastric carcinomas. Jpn
J Cancer Res 1993, 84(2):184-190.
44. Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura
H, Nomura H, Hiai H, Fukumoto M: Expression of metastasis-related
nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation
with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex
steroid receptor expression. Cancer Res 1994, 54(7):1825-1830.
45. Engel M, Theisinger B, Seib T, Seitz G, Huwer H, Zang KD, Welter C,
Dooley S: High levels of nm23-H1 and nm23-H2 messenger RNA in
human squamous-cell lung carcinoma are associated with poor
differentiation and advanced tumor stages. Int J Cancer 1993,
55(3):375-379.
46. Haut M, Steeg PS, Willson JK, Markowitz SD: Induction of nm23 gene
expression in human colonic neoplasms and equal expression in colon
tumors of high and low metastatic potential. J Natl Cancer Inst 1991,
83(10):712-716.
47. Myeroff LL, Markowitz SD: Increased nm23-H1 and nm23-H2
messenger RNA expression and absence of mutations in colon
carcinomas of low and high metastatic potential. J Natl Cancer Inst
1993, 85(2):147-152.
48. Nakamori S, Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Kameyama M,
Kabuto T, Furukawa H, Iwanakga T, Kimura N: Clinicopathological
features and prognostic significance of nucleoside diphosphate
kinase/nm23 gene product in human pancreatic exocrine neoplasms.
Int J Pancreatol 1993, 14(2):125-133.
49. Zou M, Shi Y, al-Sedairy S, Farid NR: High levels of Nm23 gene
expression in advanced stage of thyroid carcinomas. Br J Cancer 1993,
68(2):385-388.
50. Tammenkoski M, Koivula K, Cusanelli E, Zollo M, Steegborn C, Baykov
AA, Lahti R: Human metastasis regulator protein H-prune is a
short-chain exopolyphosphatase. Biochemistry 2008, 47(36):9707-9713.
51. Garzia L, D''Angelo A, Amoresano A, Knauer SK, Cirulli C, Campanella
C, Stauber RH, Steegborn C, Iolascon A, Zollo M: Phosphorylation of
nm23-H1 by CKI induces its complex formation with h-prune and
promotes cell motility. Oncogene 2008, 27(13):1853-1864.
52. Marone M, Scambia G, Ferrandina G, Giannitelli C, Benedetti-Panici P,
Iacovella S, Leone A, Mancuso S: Nm23 expression in endometrial and
cervical cancer: inverse correlation with lymph node involvement and
myometrial invasion. Br J Cancer 1996, 74(7):1063-1068.
53. Blackburn EH: Structure and function of telomeres. Nature 1991,
350(6319):569-573.
54. Ishikawa F: [A review of the structure and function of human
telomere]. Tanpakushitsu Kakusan Koso 1996, 41(15 Suppl):2241-2253.
55. Blasco MA, Rizen M, Greider CW, Hanahan D: Differential regulation
of telomerase activity and telomerase RNA during multi-stage
tumorigenesis. Nat Genet 1996, 12(2):200-204.
56. Yashima K, Vuitch F, Gazdar AF, Fahey TJ, 3rd: Telomerase activity in
benign and malignant thyroid diseases. Surgery 1997,
122(6):1141-1145; discussion 1145-1146.
57. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams
RR, Chang E, Allsopp RC, Yu J et al: The RNA component of human
telomerase. Science 1995, 269(5228):1236-1241.
58. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I,
Robinson MO: A mammalian telomerase-associated protein. Science
1997, 275(5302):973-977.
59. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD,
Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q et al: hEST2, the
putative human telomerase catalytic subunit gene, is up-regulated in
tumor cells and during immortalization. Cell 1997, 90(4):785-795.
60. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH,
Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs
from fission yeast and human. Science 1997, 277(5328):955-959.
61. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing
of human fibroblasts. Nature 1990, 345(6274):458-460.
62. Greider CW: Telomere length regulation. Annu Rev Biochem 1996,
65:337-365.
63. Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M: Telomerase activity in
gynecological tumors. Clin Cancer Res 1996, 2(12):2023-2028.
64. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey
DS: Telomerase activity: a prevalent marker of malignant human
prostate tissue. Cancer Res 1996, 56(1):218-222.
65. Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM: Analysis of
telomerase activity levels in breast cancer: positive detection at the in
situ breast carcinoma stage. Clin Cancer Res 1997, 3(1):11-16.
66. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E,
Kajiyama G, Ide T: Telomerase activity in human liver tissues:
comparison between chronic liver disease and hepatocellular
carcinomas. Cancer Res 1995, 55(13):2734-2736.
67. Langford LA, Piatyszek MA, Xu R, Schold SC, Jr., Wright WE, Shay JW:
Telomerase activity in ordinary meningiomas predicts poor outcome.
Hum Pathol 1997, 28(4):416-420.
68. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky
A, Dyson NJ: Prognostic and pathologic significance of quantitative
protein expression profiling in human gliomas. Clin Cancer Res 2001,
7(8):2387-2395.
69. Handra-Luca A, Bilal H, Bertrand JC, Fouret P: Extra-cellular
signal-regulated ERK-1/ERK-2 pathway activation in human salivary
gland mucoepidermoid carcinoma: association to aggressive tumor
behavior and tumor cell proliferation. Am J Pathol 2003,
163(3):957-967.
70. Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V,
Taranchon E, Filipits M, Pirker R, Popper HH et al: DNA repair by
ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant
chemotherapy. N Engl J Med 2006, 355(10):983-991.
71. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N,
Chauhan D, Richardson P, Munshi NC, Anderson KC: Nuclear
factor-kappaB p65 mediates tumor necrosis factor alpha-induced
nuclear translocation of telomerase reverse transcriptase protein.
Cancer Res 2003, 63(1):18-21.
72. Liu K, Hodes RJ, Weng N: Cutting edge: telomerase activation in
human T lymphocytes does not require increase in telomerase reverse
transcriptase (hTERT) protein but is associated with hTERT
phosphorylation and nuclear translocation. J Immunol 2001,
166(8):4826-4830.
73. Nakano K, Watney E, McDougall JK: Telomerase activity and expression of telomerase RNA component and telomerase catalytic
subunit gene in cervical cancer. Am J Pathol 1998, 153(3):857-864.
74. Sagawa Y, Nishi H, Isaka K, Fujito A, Takayama M: The correlation of
TERT expression with c-myc expression in cervical cancer. Cancer
Lett 2001, 168(1):45-50.
75. Wisman GB, De Jong S, Meersma GJ, Helder MN, Hollema H, de Vries
EG, Keith WN, van der Zee AG: Telomerase in (pre)neoplastic cervical
disease. Hum Pathol 2000, 31(10):1304-1312.
76. Tsezou A, Oikonomou P, Kollia P, Mademtzis I, Kostopoulou E, Messinis
I, Vamvakopoulos N: The role of human telomerase catalytic subunit
mRNA expression in cervical dysplasias. Exp Biol Med (Maywood)
2005, 230(4):263-270.
77. Zhang A, Wang J, Zheng B, Fang X, Angstrom T, Liu C, Li X, Erlandsson
F, Bjorkholm M, Nordenskjord M et al: Telomere attrition
predominantly occurs in precursor lesions during in vivo carcinogenic
process of the uterine cervix. Oncogene 2004, 23(44):7441-7447.
78. Wang PH, Chang H, Ko JL, Lin LY: Nm23-H1 immunohistochemical
expression in multisteps of cervical carcinogenesis. Int J Gynecol
Cancer 2003, 13(3):325-330.
79. Ravazoula P, Aletra C, Kourounis G, Ladopoulos I, Tzigounis V:
Immunohistochemical analysis of nm23-H1 expression in human
cervical lesions. Eur J Gynaecol Oncol 2000, 21(5):510-512.
80. Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto
A, Bonifacio D, Di Bonito P, Paba P et al: Down-regulated nucleoside
diphosphate kinase nm23-H1 expression is unrelated to high-risk
human papillomavirus but associated with progression of cervical
intraepithelial neoplasia and unfavourable prognosis in cervical
cancer. J Clin Pathol 2006, 59(10):1044-1051.
81. Weber G: Enzymology of cancer cells (first of two parts). N Engl J Med
1977, 296(9):486-492.
82. Ohneda K, Fukuda M, Shimada N, Ishikawa N, Ichou T, Kaji K, Toyota T,
Kimura N: Increased expression of nucleoside diphosphate
kinases/nm23 in human diploid fibroblasts transformed by SV40
large T antigen or 60Co irradiation. FEBS Lett 1994, 348(3):273-277.
83. Pinto AP, Crum CP: Natural history of cervical neoplasia: defining
progression and its consequence. Clin Obstet Gynecol 2000,
43(2):352-362.
84. Bravaccini S, Sanchini MA, Amadori A, Medri L, Saragoni L, Calistri D,
Monti F, Volpi A, Amadori D: Potential of telomerase expression and
activity in cervical specimens as a diagnostic tool. J Clin Pathol 2005,
58(9):911-914.
85. Sarac E, Ayhan A, Ertoy D, Tuncer ZS, Yasui W, Tahara E: nm23
expression in carcinoma of the uterine cervix. Eur J Gynaecol Oncol
1998, 19(3):312-315.
86. Postel EH: Multiple biochemical activities of NM23/NDP kinase in
gene regulation. J Bioenerg Biomembr 2003, 35(1):31-40.
87. Malins DC, Polissar NL, Gunselman SJ: Progression of human breast
cancers to the metastatic state is linked to hydroxyl radical-induced
DNA damage. Proc Natl Acad Sci U S A 1996, 93(6):2557-2563.
88. Malins DC, Polissar NL, Schaefer S, Su Y, Vinson M: A unified theory
of carcinogenesis based on order-disorder transitions in DNA
structure as studied in the human ovary and breast. Proc Natl Acad
Sci U S A 1998, 95(13):7637-7642.
89. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR,
Vogelstein B, Kinzler KW: Gene expression profiles in normal and
cancer cells. Science 1997, 276(5316):1268-1272.
90. Pinon VP, Millot G, Munier A, Vassy J, Linares-Cruz G, Capeau J, Calvo
F, Lacombe ML: Cytoskeletal association of the A and B nucleoside
diphosphate kinases of interphasic but not mitotic human carcinoma
cell lines: specific nuclear localization of the B subunit. Exp Cell Res
1999, 246(2):355-367.
91. Yamashiro S, Urano T, Shiku H, Furukawa K: Alteration of nm23 gene
expression during the induced differentiation of human leukemia cell
lines. Oncogene 1994, 9(9):2461-2468.
92. Sager R: Expression genetics in cancer: shifting the focus from DNA
to RNA. Proc Natl Acad Sci U S A 1997, 94(3):952-955.
93. Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, Husnjak K, Unusic J,
Pavelic K: Expression of c-myc, erbB-2, p53 and nm23-H1 gene
product in benign and malignant breast lesions: coexpression and
correlation with clinicopathologic parameters. Exp Mol Pathol 2005,
79(1):42-50.
94. Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg
R: Inhibition of a new differentiation pathway in neuroblastoma by
copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 2005, 65(8):3136-3145.
95. D''Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O,
Arrigoni G, Cossu A, Palmieri G, Aravind L et al: Prune cAMP
phosphodiesterase binds nm23-H1 and promotes cancer metastasis.
Cancer Cell 2004, 5(2):137-149.
96. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J: Tumor suppressor
NM23-H1 is a granzyme A-activated DNase during CTL-mediated
apoptosis, and the nucleosome assembly protein SET is its inhibitor.
Cell 2003, 112(5):659-672.
97. Forus A, D''Angelo A, Henriksen J, Merla G, Maelandsmo GM, Florenes
VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F et
al: Amplification and overexpression of PRUNE in human sarcomas
and breast carcinomas-a possible mechanism for altering the
nm23-H1 activity. Oncogene 2001, 20(47):6881-6890.
98. Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC,
Berns A, Collard JG: Identification of an invasion-inducing gene,
Tiam-1, that encodes a protein with homology to GDP-GTP
exchangers for Rho-like proteins. Cell 1994, 77(4):537-549.
99. Marino N, Zollo M: Understanding h-prune biology in the fight
against cancer. Clin Exp Metastasis 2007, 24(8):637-645.
100. Otsuki Y, Tanaka M, Yoshii S, Kawazoe N, Nakaya K, Sugimura H:
Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by
interaction with Tiam1. Proc Natl Acad Sci U S A 2001,
98(8):4385-4390.
101. Reymond A, Volorio S, Merla G, Al-Maghtheh M, Zuffardi O, Bulfone A,
Ballabio A, Zollo M: Evidence for interaction between human PRUNE
and nm23-H1 NDPKinase. Oncogene 1999, 18(51):7244-7252.
102. Valentijn LJ, Koster J, Versteeg R: Read-through transcript from
NM23-H1 into the neighboring NM23-H2 gene encodes a novel
protein, NM23-LV. Genomics 2006, 87(4):483-489.
103. Ni X, Gu S, Dai J, Cheng H, Guo L, Li L, Ji C, Xie Y, Ying K, Mao Y:
Isolation and characterization of a novel human NM23-H1B gene, a
different transcript of NM23-H1. J Hum Genet 2003, 48(2):96-100.
104. Kristensen GB, Holm R, Abeler VM, Trope CG: Evaluation of the
prognostic significance of nm23/NDP kinase protein expression in
cervical carcinoma: an immunohistochemical study. Gynecol Oncol
1996, 61(3):378-383.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文